Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIN-1 fecal microbiota transplantation for children with autism spectrum disorder
jRCTs031230041Completed
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of SHIN1 in Autism Spectrum Disorder (ASD). Primary endpoint: SRS-2 total and core symptom change. Started Apr 2023; status: completed.
02
Drugs
SHIN1
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on jRCTs031230041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230041.